Literature DB >> 30915535

Is the grade of ballooned hepatocytes a significant risk factor for rapid progression of hepatic fibrosis in patients with NAFLD?

Yoshio Sumida1, Masashi Yoneda2, Takeshi Okanoue3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30915535     DOI： 10.1007/s00535-019-01573-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  8 in total

1.  Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Keisuke Kakisaka; Yuji Suzuki; Yudai Fujiwara; Tamami Abe; Miki Yonezawa; Hidekatsu Kuroda; Kazuyuki Ishida; Tamotsu Sugai; Yasuhiro Takikawa
Journal:  J Gastroenterol       Date:  2018-04-21       Impact factor: 7.527

2.  The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study.

Authors:  Hiroshi Ishiba; Yoshio Sumida; Saiyu Tanaka; Masato Yoneda; Hideyuki Hyogo; Masafumi Ono; Hideki Fujii; Yuichiro Eguchi; Yasuaki Suzuki; Masashi Yoneda; Hirokazu Takahashi; Takashi Nakahara; Yuya Seko; Kojiro Mori; Kazuyuki Kanemasa; Keiji Shimada; Sunsuke Imai; Kento Imajo; Takumi Kawaguchi; Atsushi Nakajima; Kazuaki Chayama; Toshiji Saibara; Toshihide Shima; Kazuma Fujimoto; Takeshi Okanoue; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2018-05-09       Impact factor: 7.527

3.  Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.

Authors:  Mohammad Shadab Siddiqui; Goro Yamada; Raj Vuppalanchi; Mark Van Natta; Rohit Loomba; Cynthia Guy; Danielle Brandman; James Tonascia; Naga Chalasani; Brent Neuschwander-Tetri; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-04       Impact factor: 11.382

4.  A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis.

Authors:  Takeshi Okanoue; Hayao Ebise; Toshihiro Kai; Masayuki Mizuno; Toshihide Shima; Junji Ichihara; Mikio Aoki
Journal:  J Gastroenterol       Date:  2017-06-06       Impact factor: 7.527

5.  Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Arun J Sanyal; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2019-03-07       Impact factor: 17.425

6.  Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis.

Authors:  Naga Chalasani; Manal F Abdelmalek; Rohit Loomba; Kris V Kowdley; Arthur J McCullough; Srinivasan Dasarathy; Brent A Neuschwander-Tetri; Norah Terrault; Beatrice Ferguson; Reshma Shringarpure; David Shapiro; Arun J Sanyal
Journal:  Liver Int       Date:  2019-02-21       Impact factor: 5.828

7.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Amy G Shah; Alison Lydecker; Karen Murray; Brent N Tetri; Melissa J Contos; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382

8.  Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.

Authors:  Yoshio Sumida; Masato Yoneda; Hideyuki Hyogo; Yoshito Itoh; Masafumi Ono; Hideki Fujii; Yuichiro Eguchi; Yasuaki Suzuki; Noriaki Aoki; Kazuyuki Kanemasa; Koji Fujita; Kazuaki Chayama; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  BMC Gastroenterol       Date:  2012-01-05       Impact factor: 3.067
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.